"From pharmacists to therapists" About 1 in 8 Americans have tried a GLP-1 drug for weight loss or diabetes, according to a Kaiser Family Foundation poll
However, glucagon also affects blood-glucose regulation
By enhancing glucose-dependent insulin secretion, suppressing glucagon, delaying gastric emptying, and signaling satiety centers in the central nervous system, these pharmacotherapies achieve robust glycemic control and significant weight reduction
Meanwhile, GLP-1 receptor agonists deliver substantial cardiometabolic benefits
Its here to walk you through what the research actually shows, what the specific nutritional risks look like for a growing kid, and how to build the right support around your child if this is part of their care plan